DCF — METHODIST DALLAS MEDICAL CENTER
Enterprise Value: $-521.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-521.8M
Enterprise Value
$-173.4M
PV of Cash Flows
$-348.5M
PV of Terminal Value
$-561.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $572.3M | $-28.0M | -5.0% | $-52.2M | $-47.5M |
| Year 2 | $589.5M | $-22.9M | -4.0% | $-47.9M | $-39.6M |
| Year 3 | $607.2M | $-17.6M | -3.0% | $-43.3M | $-32.5M |
| Year 4 | $625.4M | $-15.0M | -2.0% | $-41.4M | $-28.3M |
| Year 5 | $644.2M | $-13.8M | -2.0% | $-41.1M | $-25.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-521.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$555.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.053916982532411006
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5